In that case, inducing pro-IL-1β degradation in cardiac cells may limit subsequent inflammatory responses to cardiac tissue damage and hence serve as a cardio protective prophylactic intervention in patients with ischemic heart disease or heart failure. This evidence concerns the gene IL1B and heart failure.